Chief Financial Officer
Chief Financial Officer at Avalo Therapeutics, Inc., filing insider transactions between 2026-04-01 and 2026-05-07.
| SEC ↗ |
| 2026-05-06 | AVTX | Sale | 2,700 | $20.76 | $56K | SEC ↗ |
| 2026-05-06 | AVTX | Sale | 8,900 | $22.57 | $201K | SEC ↗ |
| 2026-05-06 | AVTX | Sale | 9,219 | $21.37 | $197K | SEC ↗ |
| 2026-04-30 | AVTX | Sale | 8,457 | $13.23 | $112K | SEC ↗ |
| 2026-04-29 | AVTX | Sale | 8,458 | $13.09 | $111K | SEC ↗ |
| 2026-04-02 | AVTX | Sale | 1,780 | $17.57 | $31K | SEC ↗ |
| 2026-04-02 | AVTX | Sale | 6,200 | $17.02 | $106K | SEC ↗ |
| 2026-04-01 | AVTX | Sale | 500 | $15.86 | $8K | SEC ↗ |
| 2026-04-01 | AVTX | Sale | 7,479 | $16.83 | $126K | SEC ↗ |